Joseph Kleiman, president of Buzz Health, discusses the impact of Trump RX on transparency in drug pricing. In his conversation with Pharmaceutical Executive, he emphasizes the importance of early price visibility to help consumers make informed decisions, noting the dynamic nature of prices and potential shortages.